BioSpace - OraVax, Inc. News, Search Jobs, Events
Company Profile. OraVax, Inc. 38 Sidney Street Cambridge Massachusetts 02139 U.S.A.. Phone: 617-494-1339 Fax: 617-494-1741. SEARCH JOBS. Industry ...
http://www.biospace.com/company_profile.aspx?CompanyId=1467...
|
OraVax Announces Reorganization; Reduces Operating Costs
As a result, following the reorganization, OraVax will have 65 full-time employees. Positions related to early manufacturing start-up and marketing were
the ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Note: Comparison of Four Serological Tests To Determine the CagA ...
We also acknowledge the support of OraVax Inc. for providing us with the recombinant CagA antigen (orv220). We thank Jiro Imanishi and Masakazu Kita ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC105352/...
|
OraVax, Inc. Reports 1998 Third Quarter Results
16 /PRNewswire/ -- OraVax, Inc. (Nasdaq: ORVX) reported financial results today for the third quarter. OraVax's net loss to common shareholders for the ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
CDC - Strengthening National Preparedness for Smallpox: an Update
OraVax will coordinate full clinical testing of the vaccine and submit a licensing ... The agreement allows OraVax to produce additional vaccine for
other ...
http://www.cdc.gov/ncidod/EID/vol7no1/leduc.htm...
|
Rectal and Intranasal Immunizations with Recombinant Urease Induce ...
Mailing address: OraVax, Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 494-1339. Fax: (617) 494-1741. E-mail: hkleanth/at/oravax.com. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=10...
|
Research Update
into an agreement with OraVax (Cambridge, ... OraVax will coordinate full clinical testing of the vac- ... produced by OraVax), which create a localized
...
http://www.cdc.gov/ncidod/EID/vol7no1/pdfs/luduc.pdf...
|
TYPES list archives
Confluence for typed terms oravax!garrel@wrath.cs.cornell.edu (Garrel Pottinger) .... Descriptions, Excluded Middle, and Constructions oravax!eurylochus. ...
http://www.seas.upenn.edu/~sweirich/types/archive/1989/...
|
Safety and Immunogenicity of Increasing Doses of a Clostridium ...
The final product passed safety tests developed at OraVax (Cambridge, Mass.) for mouse toxicity (0.5-mg intraperitoneal dose) and cytotoxicity (up to 0.25 ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=97...
|
Serum Antitoxin Antibodies Mediate Systemic and Mucosal Protection ...
Mailing address: OraVax, Inc., 38 Sidney St., Cambridge, MA 02139. ..... or rabbit anti-hamster IgA (prepared at OraVax, Inc., with hamster colostral IgA as
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC96351/...
|
